CTCBIO Inc - Asset Resilience Ratio

Latest as of March 2025: 0.00%

CTCBIO Inc (060590) has an Asset Resilience Ratio of 0.00% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩80.00

≈ $0.05 USD Cash + Short-term Investments

Total Assets

₩148.81 Billion

≈ $100.85 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how CTCBIO Inc's Asset Resilience Ratio has changed over time. Check strategic asset allocation of CTCBIO Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down CTCBIO Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is CTCBIO Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩80.00	0.0%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩80.00	0.00%

Asset Resilience Insights

Limited Liquidity: CTCBIO Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

CTCBIO Inc Industry Peers by Asset Resilience Ratio

Compare CTCBIO Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
ALTEOGEN Inc KQ:196170	Biotechnology	55.57%
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	Biotechnology	47.01%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	34.94%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Inventiva S.A PA:IVA	Biotechnology	52.73%

Annual Asset Resilience Ratio for CTCBIO Inc (2011–2024)

The table below shows the annual Asset Resilience Ratio data for CTCBIO Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.00%	₩370.00 ≈ $0.25	₩153.69 Billion ≈ $104.15 Million	-0.03pp
2023-12-31	0.03%	₩50.00 Million ≈ $33.88K	₩165.86 Billion ≈ $112.40 Million	-12.93pp
2022-12-31	12.96%	₩24.35 Billion ≈ $16.50 Million	₩187.90 Billion ≈ $127.34 Million	+8.41pp
2021-12-31	4.55%	₩7.65 Billion ≈ $5.19 Million	₩168.23 Billion ≈ $114.00 Million	-3.71pp
2020-12-31	8.26%	₩14.64 Billion ≈ $9.92 Million	₩177.17 Billion ≈ $120.07 Million	-0.65pp
2019-12-31	8.91%	₩16.62 Billion ≈ $11.27 Million	₩186.50 Billion ≈ $126.39 Million	+1.60pp
2018-12-31	7.31%	₩14.02 Billion ≈ $9.50 Million	₩191.69 Billion ≈ $129.90 Million	+2.72pp
2017-12-31	4.60%	₩8.82 Billion ≈ $5.97 Million	₩191.80 Billion ≈ $129.98 Million	+1.05pp
2016-12-31	3.55%	₩6.69 Billion ≈ $4.53 Million	₩188.68 Billion ≈ $127.86 Million	+2.44pp
2015-12-31	1.11%	₩2.15 Billion ≈ $1.46 Million	₩193.61 Billion ≈ $131.21 Million	-0.77pp
2014-12-31	1.88%	₩3.04 Billion ≈ $2.06 Million	₩162.12 Billion ≈ $109.87 Million	-15.22pp
2013-12-31	17.10%	₩25.73 Billion ≈ $17.43 Million	₩150.48 Billion ≈ $101.98 Million	+14.55pp
2012-12-31	2.54%	₩3.19 Billion ≈ $2.16 Million	₩125.36 Billion ≈ $84.96 Million	+1.69pp
2011-12-31	0.86%	₩801.82 Million ≈ $543.38K	₩93.33 Billion ≈ $63.25 Million	--

pp = percentage points

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$47.31 Million

₩69.81 Billion KRW

Market Cap Rank

#22040 Global

#1326 in Korea

Share Price

₩2920.00

Change (1 day)

+5.80%

52-Week Range

₩2700.00 - ₩7450.00

All Time High

₩18000.00